Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3,065.99 | 9.49 |
PEG Ratio (TTM) | -526.75 | -144.63 |
P/S Ratio (TTM) | 0.41 | 0.49 |
P/B Ratio (TTM) | 1.19 | 1.42 |
P/FCF Ratio (TTM) | 20.81 | 14.16 |
Price to 5YR AVG Earnings Ratio | 11.36 | 13.36 |
Price to 5YR AVG FCF Ratio | 15.04 | 66.07 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.02% | 4.08% |
ROE (TTM) | -0.04% | 3.38% |
Net Profit Margin (TTM) | -0.01% | 0.31% |
ROIC 5YR AVG | 8.78% | 11.40% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 45.74% | 19.70% | -8.18% |
Revenue | 0.42% | 8.01% | -15.19% |
Net Income | 45.78% | 19.40% | -8.36% |
Cash Flow | 222.28% | 12.70% | -5.35% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.82 | 1.96 |
Quick Ratio (TTM) | 0.95 | 1.16 |
D/E Ratio (TTM) | 0.61 | 0.54 |
Interest Coverage (TTM) | 1.04 | 5.30 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.96 | 3.64 |
LTL to 5YR AVG FCF | 5.31 | 16.93 |
Shares Outstanding Growth 5YR AVG | -20.17% | -6.89% |